| |
|
|
|
Alpine Immune Sciences Inc  
|
|
12.79 -0.33 (-0.03%) |
01-25 12:29 |
|
Open: |
13.2 |
Pre close: |
13.12 |
Target:
|
17.26
|
|
High: |
13.4612 |
Low: |
12.455 |
Resistance:
|
14.77
16.37
|
|
Volume: |
40,819 |
Market Cap: |
304M |
Support:
|
12.19
10.14
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
13.05
 |
MACD |
MACD(12,26):
|
0.21 |
|
MA(20): |
13.42 |
Signal(12,26,9): |
0.42 |
|
MA(100): |
9.93  |
Stochastic Oscillator |
%K(14,3):
|
41.92 |
|
MA(250): |
7.25 |
%D(3): |
39.73 |
|
Average Volume(K) |
3-Month: |
9745
|
52-Week |
High:
|
16.37 |
|
10-Days: |
11024 |
Low: |
2.05 |
|
RSI |
RSI(14):
|
48.55 |
Change(%): |
342.1 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.420 |
Return on Equity (ttm) |
-54.2 |
Shares Out. (M) |
23.80 |
|
EPS Est. Current Year |
-3.180 |
Return on Assets (ttm) |
-16.7 |
Shares Float (M) |
8.78 |
|
EPS Est. Next Year |
-2.500 |
PEG Ratio |
0.00 |
% Held by Insiders |
28.49 |
|
EPS Est. Next Quarter |
-1.030 |
Qtrly Rev. Growth |
561.9 |
% Held by Institutions |
52.56 |
|
Forward EPS |
-2.280 |
Gross Profit (p.s.) |
-1.433 |
Shares Short (K) |
28 |
|
Book Value (p.s.) |
2.830 |
EBITDA (p.s.) |
-1.208 |
P/E |
-9.03 |
|
Sales Per Share |
0.192 |
Qtrly Earnings Growth |
0.00 |
P/BV |
4.53 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
33.76 |
P/S |
66.62 |
|
Operating Margin |
-640.41 |
Levered Free Cash Flow
(M) |
9.99 |
P/CF |
9.04 |
|
|
|
|
|
|
